Class IIITerminatedD-1663-2012
Drug recall · September 5, 2012
Bracco Diagnostics multihance recall
Why: Short Fill: The product is being recalled due to a potential underfill of the affected vials.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Bracco Diagnostics multihance (gadobenate dimeglumine) injection, 529 mg/mL, 20ml, Rx only, Manufactured for: Bracco Diagnostics Inc., Princeton, NJ 08543 USA, NDC 0270-5164-15
- Lots / codes
Lot S1P272A Expiry Date: December 2014
- Quantity
- 47,750 vials
- Company
- Bracco Diagnostics Inc, Monroe Township, NJ
- Distribution
- Nationwide
- Initiated
- April 16, 2012 · Voluntary: Firm initiated
- Classified
- August 27, 2012
- Reported
- September 5, 2012
- Ended
- July 8, 2013
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.